A comparison of commercially available adjuvants for use in research

Amyx, 1987, Control of animal pain and distress in antibody production and infectious disease studies, J. Am. Vet. Med. Assoc., 191, 1287 Becher, 1965, Theory of emulsions: stability, 95 Broderson, 1989, A retrospective review of lesions associated with the use of Freund's adjuvant, Lab. Animal Sci., 39, 400 Freund, 1937, Sensitization and antibody formation after injection of tubercle bacilli and paraffin oil, 37, 509 Freund, 1951, The effect of paraffin oil and mycobacteria on antibody formation and sensitization, Am. J. Clin. Pathol., 21, 645, 10.1093/ajcp/21.7.645 Garvey, 1977, DNP- and TNP-conjugated proteins, 153 Hilleman, 1967, Considerations for safety and application of emulsified oil adjuvants to viral vaccines, Vol. 6, 18 Hunter, 1981, Studies on the adjuvant activity of nonionic block polymer surfactants. I. The role of hydrophile-lipophile balance, J. Immunol., 127, 1244, 10.4049/jimmunol.127.3.1244 Hunter, 1984, Studies on the adjuvant activity of nonionic block polymer surfactants. II. Antibody formation and inflammation related to the structure of triblock and octablock copolymers, J. Immunol., 133, 1367, 10.4049/jimmunol.133.6.3167 Hunter, 1986, The adjuvant activity of nonionic block polymer surfactants. III. Characterization of selected biologically active surfaces, Scand. J. Immunol., 23, 287, 10.1111/j.1365-3083.1986.tb01970.x Hunter, 1991, Adjuvant activity of non-ionic block copolymers. IV. Effect of molecular weight and formulation on titre and isotype of antibody, Vaccine, 9, 250, 10.1016/0264-410X(91)90108-I Jennes, 1983, Preparation and use of specific antibodies for immunohistochemistry of neuropeptides, Vol. 103, 448 Takayama, 1991, Adjuvant activity of non-ionic block copolymers. V. Modulation of antibody isotype by lipopolysaccharides, lipid A and precursors, Vaccine, 9, 257, 10.1016/0264-410X(91)90109-J